These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study. Calle Rubio M; Casamor R; Miravitlles M Int J Chron Obstruct Pulmon Dis; 2017; 12():2373-2383. PubMed ID: 28848338 [TBL] [Abstract][Full Text] [Related]
6. Roflumilast for the treatment of chronic obstructive pulmonary disease. Antoniu SA Curr Opin Investig Drugs; 2006 May; 7(5):412-7. PubMed ID: 16729716 [TBL] [Abstract][Full Text] [Related]
7. Clinical phenotypes of COPD: identification, definition and implications for guidelines. Miravitlles M; Calle M; Soler-Cataluña JJ Arch Bronconeumol; 2012 Mar; 48(3):86-98. PubMed ID: 22196477 [TBL] [Abstract][Full Text] [Related]
8. [Toward personalized and integrated treatment of patients with COPD]. Ancochea J; Gómez García T; de Miguel Díez J Arch Bronconeumol; 2010 Dec; 46 Suppl 10():14-8. PubMed ID: 21316551 [TBL] [Abstract][Full Text] [Related]
10. [Pharmacological treatment of COPD. Where are we now?]. Calle Rubio M; Pinedo Sierra C; Rodríguez Hermosa JL Arch Bronconeumol; 2010 Dec; 46 Suppl 10():3-7. PubMed ID: 21316549 [TBL] [Abstract][Full Text] [Related]
11. [Moving towards a new focus on COPD. The Spanish COPD Guidelines (GESEPOC)]. Grupo de Trabajo de GESEPOC Arch Bronconeumol; 2011 Aug; 47(8):379-81. PubMed ID: 21757283 [No Abstract] [Full Text] [Related]
12. A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC). Miravitlles M; Soler-Cataluña JJ; Calle M; Molina J; Almagro P; Quintano JA; Trigueros JA; Piñera P; Simón A; Riesco JA; Ancochea J; Soriano JB Prim Care Respir J; 2013 Mar; 22(1):117-21. PubMed ID: 23443227 [TBL] [Abstract][Full Text] [Related]
13. Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype. Lee JH; Lee YK; Kim EK; Kim TH; Huh JW; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Sheen SS; Kim N; Seo JB; Oh YM; Lee SD Respir Med; 2010 Apr; 104(4):542-9. PubMed ID: 19926461 [TBL] [Abstract][Full Text] [Related]
14. Optimizing Drug Therapies in Patients with COPD in the US Nursing Home Setting. Pleasants RA; Radlowski PA; Davidson HE Drugs Aging; 2019 Aug; 36(8):733-745. PubMed ID: 31172422 [TBL] [Abstract][Full Text] [Related]
16. Geographic variations of the prevalence and distribution of COPD phenotypes in Spain: "the ESPIRAL-ES study". Alcázar-Navarrete B; Trigueros JA; Riesco JA; Campuzano A; Pérez J Int J Chron Obstruct Pulmon Dis; 2018; 13():1115-1124. PubMed ID: 29692606 [TBL] [Abstract][Full Text] [Related]
17. Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice. Miravitlles M; Soler-Cataluña JJ; Calle M; Soriano JB Eur Respir J; 2013 Jun; 41(6):1252-6. PubMed ID: 23060631 [TBL] [Abstract][Full Text] [Related]
18. Consensus on the Asthma-COPD Overlap Syndrome (ACOS) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA). Plaza V; Álvarez F; Calle M; Casanova C; Cosío BG; López-Viña A; Pérez de Llano L; Quirce S; Román-Rodríguez M; Soler-Cataluña JJ; Miravitlles M Arch Bronconeumol; 2017 Aug; 53(8):443-449. PubMed ID: 28495077 [TBL] [Abstract][Full Text] [Related]
19. [Pharmacological treatment of COPD and future of anti-inflammatory therapy]. Watz H; Bitter-Suermann S; Kanniess F; Magnussen H Med Klin (Munich); 2006 Apr; 101(4):283-92. PubMed ID: 16607484 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD). Izquierdo-Alonso JL; Rodriguez-Gonzálezmoro JM; de Lucas-Ramos P; Unzueta I; Ribera X; Antón E; Martín A Respir Med; 2013 May; 107(5):724-31. PubMed ID: 23419828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]